| Cell line name |
MFUM-BrTNBC-1 |
| Synonyms |
Medical Faculty University of Maribor-Breast Triple Negative Breast Cancer-1 |
| Accession |
CVCL_B5N7 |
| Resource Identification Initiative |
To cite this cell line use: MFUM-BrTNBC-1 (RRID:CVCL_B5N7) |
| Comments |
Group: Triple negative breast cancer (TNBC) cell line. Population: Caucasian; Slovenian. Characteristics: Shown by ICC and PCR to be ER-negative, PR-negative and ERBB2-negative (PubMed=35011679). Doubling time: 80 hours (PubMed=35011679). Derived from site: In situ; Breast; UBERON=UBERON_0000310. |
| Sequence variations |
- Mutation; HGNC; HGNC:393; AKT3; Simple; p.Lys294Ter (c.880A>T); Zygosity=Heterozygous (PubMed=35011679).
- Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Tyr2037Ter (c.6111C>G); Zygosity=Heterozygous (PubMed=35011679).
- Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly32Arg (c.94G>C); ClinVar=VCV001690925; Zygosity=Heterozygous (PubMed=35011679).
- Mutation; HGNC; HGNC:7993; NRBP1; Simple; p.Lys217Ter (c.649A>T); Zygosity=Heterozygous (PubMed=35011679).
- Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=35011679).
- Mutation; HGNC; HGNC:12816; XPC; Simple; p.Gln829Ter (c.2485C>T); Zygosity=Heterozygous (PubMed=35011679).
|
| Disease |
Invasive breast carcinoma of no special type (NCIt: C4194) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Sex of cell |
Female |
| Age at sampling |
47Y |
| Category |
Cancer cell line |
| STR profile |
Source(s): PubMed=35011679
Markers:| Amelogenin | X |
| CSF1PO | 11 |
| D2S1338 | 22,24 |
| D3S1358 | 15 |
| D5S818 | 12 |
| D7S820 | 9,11 |
| D8S1179 | 12,14 |
| D13S317 | 13,14 |
| D16S539 | 11,12 |
| D18S51 | 12,16 |
| D19S433 | 13,14 |
| D21S11 | 28,31.2 |
| FGA | 23 |
| TH01 | 6 |
| TPOX | 8,9 |
| vWA | 17,19 |
Run an STR similarity search on this cell line |
| Publications | PubMed=31749235; DOI=10.1111/tbj.13695 Kristijan Skok, Lidija Gradisnik, Helena Sabina Celesnik, Uros Potocnik, Rajko Kavalar, Iztok Takac, Uros Maver; Isolation and characterization of the first Slovenian human triple-negative breast cancer cell line. Breast J. 26:328-330(2020) PubMed=35011679; DOI=10.3390/cells11010117; PMCID=PMC8749978 Kristijan Skok, Lidija Gradisnik, Helena Sabina Celesnik, Marko Milojevic, Uros Potocnik, Gregor Jezernik, Mario Gorenjak, Monika Sobocan, Iztok Takac, Rajko Kavalar, Uros Maver; MFUM-BrTNBC-1, a newly established patient-derived triple-negative breast cancer cell line: molecular characterisation, genetic stability, and comprehensive comparison with commercial breast cancer cell lines. Cells 11:117.1-117.23(2022) |
| Cross-references |
| Encyclopedic resources |
Wikidata; Q112129315
|
| Entry history |
| Entry creation | 17-Mar-2022 |
| Last entry update | 19-Dec-2024 |
| Version number | 6 |
|---|